300381 溢多利
已收盘 05-15 15:00:00
资讯
新帖
简况
溢多利（300381）披露回购股份注销完成暨股份变动公告，5月13日股价上涨0.94%
证券之星 · 05-13 22:36
溢多利（300381）披露回购股份注销完成暨股份变动公告，5月13日股价上涨0.94%
溢多利(300381)4月30日股东户数2万户，较上期减少0.92%
证券之星 · 05-11
溢多利(300381)4月30日股东户数2万户，较上期减少0.92%
股市必读：溢多利（300381）5月8日披露最新机构调研信息
证券之星 · 05-11
股市必读：溢多利（300381）5月8日披露最新机构调研信息
每周股票复盘：溢多利（300381）Q1净利增238.47%
证券之星 · 05-03
每周股票复盘：溢多利（300381）Q1净利增238.47%
溢多利（300381）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 04-30
溢多利（300381）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
图解溢多利一季报：第一季度单季净利润同比增长238.47%
证券之星 · 04-28
图解溢多利一季报：第一季度单季净利润同比增长238.47%
溢多利(300381.SZ)发布一季度业绩，归母净利润1648.54万元，增长238.47%
智通财经 · 04-28
溢多利(300381.SZ)发布一季度业绩，归母净利润1648.54万元，增长238.47%
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
证券之星 · 04-25
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
图解溢多利年报：第四季度单季净利润同比下降224.46%
证券之星 · 04-25
图解溢多利年报：第四季度单季净利润同比下降224.46%
溢多利（300381）披露注销回购股份并减少注册资本公告，4月20日股价下跌0.16%
证券之星 · 04-20
溢多利（300381）披露注销回购股份并减少注册资本公告，4月20日股价下跌0.16%
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
证券之星 · 04-07
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
股市必读：溢多利（300381）4月1日董秘有最新回复
证券之星 · 04-02
股市必读：溢多利（300381）4月1日董秘有最新回复
溢多利公布国际专利申请：“碱性蛋白酶突变体及其应用”
证券之星 · 03-07
溢多利公布国际专利申请：“碱性蛋白酶突变体及其应用”
溢多利（300381）披露向2025年限制性股票激励计划激励对象授予预留限制性股票的公告，3月6日股价上涨3.76%
证券之星 · 03-06
溢多利（300381）披露向2025年限制性股票激励计划激励对象授予预留限制性股票的公告，3月6日股价上涨3.76%
溢多利（300381）披露产品获得欧盟批准注册公告，3月2日股价下跌4.13%
证券之星 · 03-02
溢多利（300381）披露产品获得欧盟批准注册公告，3月2日股价下跌4.13%
溢多利：截至2026年2月27日，公司股东人数为20415户
证券之星 · 03-02
溢多利：截至2026年2月27日，公司股东人数为20415户
溢多利最新公告：公司产品获得欧盟批准注册
证券之星 · 03-01
溢多利最新公告：公司产品获得欧盟批准注册
溢多利：公司立足生物产业，致力于生物技术在营养与健康、食品饮料、护理清洁、纺织皮革、纸浆造纸、生物能源、生态农业、再生资源等领域的绿色、安全、高效应用
证券之星 · 02-10
溢多利：公司立足生物产业，致力于生物技术在营养与健康、食品饮料、护理清洁、纺织皮革、纸浆造纸、生物能源、生态农业、再生资源等领域的绿色、安全、高效应用
股市必读：溢多利(300381)股东户数2.01万户，较上期增加1.11%
证券之星 · 02-03
股市必读：溢多利(300381)股东户数2.01万户，较上期增加1.11%
溢多利最新公告：2025年预亏1300万元—2600万元同比由盈转亏
证券之星 · 01-28
溢多利最新公告：2025年预亏1300万元—2600万元同比由盈转亏
加载更多
公司概况
公司名称：
广东溢多利生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2014-01-28
主营业务：
广东溢多利生物科技股份有限公司的主营业务是生物酶制剂、生物合成品及植物提取物的研发、生产、销售和服务，并向客户提供整体生物技术解决方案。公司的主要产品是生物酶制剂、生物合成品、植物提取物。公司荣获了国家工信部认定的“饲料用酶制剂产品国家制造业单项冠军企业”荣誉称号。
发行价格：
27.88
{"stockData":{"symbol":"300381","market":"SZ","secType":"STK","nameCN":"溢多利","latestPrice":7.47,"timestamp":1778828607000,"preClose":7.4,"halted":0,"volume":12887203,"delay":0,"changeRate":0.0095,"floatShares":478000000,"shares":480000000,"eps":-0.0171,"marketStatus":"已收盘","change":0.07,"latestTime":"05-15 15:00:00","open":7.43,"high":7.53,"low":7.37,"amount":95918000,"amplitude":0.0216,"askPrice":7.48,"askSize":331,"bidPrice":7.47,"bidSize":407,"shortable":0,"etf":0,"ttmEps":-0.0171,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":7.4,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":8.14,"lowLimit":6.66,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":480173861,"isCdr":false,"pbRate":1.38,"roa":"--","roe":"0.64%","epsLYR":-0.0403,"committee":-0.346821,"marketValue":3587000000,"turnoverRate":0.0269,"status":0,"floatMarketCap":3574000000},"requestUrl":"/m/hq/s/300381/","defaultTab":"news","newsList":[{"id":"2635358597","title":"溢多利（300381）披露回购股份注销完成暨股份变动公告，5月13日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635358597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635358597?lang=zh_cn&edition=full","pubTime":"2026-05-13 22:36","pubTimestamp":1778682976,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，溢多利报收于7.49元，较前一交易日上涨0.94%，最新总市值为36.78亿元。近日，广东溢多利生物科技股份有限公司发布《关于回购股份注销完成暨股份变动的公告》。公告显示，本次注销回购股份数量为10,887,600股，占注销前总股本的2.22%。注销完成后，公司总股本由491,061,461股变更为480,173,861股。本次回购股份原计划用于员工持股计划或股权激励，因在36个月内未使用，经董事会及股东大会审议通过，变更用途为注销并减少注册资本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300045844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300381","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634404258","title":"溢多利(300381)4月30日股东户数2万户，较上期减少0.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634404258","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634404258?lang=zh_cn&edition=full","pubTime":"2026-05-11 17:27","pubTimestamp":1778491665,"startTime":"0","endTime":"0","summary":"证券之星消息，近日溢多利披露，截至2026年4月30日公司股东户数为2.0万户，较3月31日减少186.0户，减幅为0.92%。在化学制药行业个股中，溢多利股东户数低于行业平均水平，截至4月30日，化学制药行业平均股东户数为3.59万户。从股价来看，2026年3月31日至2026年4月30日，溢多利区间涨幅为5.65%，在此期间股东户数减少186.0户，减幅为0.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100024114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","BK0239","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634242999","title":"股市必读：溢多利（300381）5月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2634242999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634242999?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:08","pubTimestamp":1778443693,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，溢多利报收于7.37元，上涨6.2%，换手率4.78%，成交量23.38万手，成交额1.69亿元。公司已于2022年4月出售生物医药相关资产，2025年无医药中间体、甾体激素业务。国内覆盖25个省市，海外布局60多个国家和地区，拥有全球2300多家长期合作优质客户；持续推进“人才与渠道本土化”战略，积极参与展会与技术交流，设立海外分支机构深化布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300381","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632722626","title":"每周股票复盘：溢多利（300381）Q1净利增238.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632722626","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632722626?lang=zh_cn&edition=full","pubTime":"2026-05-03 04:51","pubTimestamp":1777755067,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，溢多利报收于6.92元，较上周的6.19元上涨11.79%。本周，溢多利4月29日盘中最高价报7.13元。本周关注点来自业绩披露要点：溢多利2026年一季度归母净利润同比上升238.47%。股本股东变化股东户数变动截至2026年3月31日，溢多利股东户数为2.02万户，较2月27日减少205.0户，减幅1.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300381","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631520017","title":"溢多利（300381）2026年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631520017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631520017?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:42","pubTimestamp":1777502527,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期溢多利发布2026年一季报。截至本报告期末，公司营业总收入2.13亿元，同比上升5.06%，归母净利润1648.54万元，同比上升238.47%。本报告期溢多利盈利能力上升，毛利率同比增幅5.22%，净利率同比增幅227.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000022620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630370536","title":"图解溢多利一季报：第一季度单季净利润同比增长238.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630370536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630370536?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:23","pubTimestamp":1777371809,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利2026年一季报显示，一季度公司主营收入2.13亿元，同比上升5.06%；归母净利润1648.54万元，同比上升238.47%；扣非净利润1126.41万元，同比上升30.61%；负债率9.27%，投资收益54.42万元，财务费用356.1万元，毛利率49.66%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800054347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630372407","title":"溢多利(300381.SZ)发布一季度业绩，归母净利润1648.54万元，增长238.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630372407","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630372407?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:55","pubTimestamp":1777370110,"startTime":"0","endTime":"0","summary":"智通财经APP讯，溢多利(300381.SZ)发布2026年第一季度报告，该公司营业收入为2.13亿元，同比增长5.06%。归属于上市公司股东的净利润为1648.54万元，同比增长238.47%。归属于上市公司股东的扣除非经常性损益的净利润为1126.41万元，同比增长30.61%。基本每股收益为0.0336元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435346.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"溢多利(300381.SZ)发布一季度业绩，归母净利润1648.54万元，增长238.47%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630870599","title":"溢多利(300381)3月31日股东户数2.02万户，较上期减少1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870599?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:12","pubTimestamp":1777108336,"startTime":"0","endTime":"0","summary":"证券之星消息，近日溢多利披露，截至2026年3月31日公司股东户数为2.02万户，较2月27日减少205.0户，减幅为1.0%。在化学制药行业个股中，溢多利股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.52万户。从股价来看，2026年2月27日至2026年3月31日，溢多利区间跌幅为6.83%，在此期间股东户数减少205.0户，减幅为1.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500032667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0070","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630182920","title":"图解溢多利年报：第四季度单季净利润同比下降224.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630182920","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630182920?lang=zh_cn&edition=full","pubTime":"2026-04-25 01:19","pubTimestamp":1777051163,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利2025年年报显示，当年度公司主营收入8.32亿元，同比上升0.73%；归母净利润-1977.95万元，同比下降163.62%；扣非净利润-1803.89万元，同比下降401.44%；其中2025年第四季度，公司单季度主营收入2.19亿元，同比上升0.64%；单季度归母净利润-3798.39万元，同比下降224.46%；单季度扣非净利润-3680.62万元，同比下降356.79%；负债率11.34%，投资收益176.02万元，财务费用-540.51万元，毛利率45.42%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500003921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628172182","title":"溢多利（300381）披露注销回购股份并减少注册资本公告，4月20日股价下跌0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628172182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628172182?lang=zh_cn&edition=full","pubTime":"2026-04-20 22:28","pubTimestamp":1776695291,"startTime":"0","endTime":"0","summary":"近日，广东溢多利生物科技股份有限公司披露《关于注销回购股份并减少注册资本暨通知债权人的公告》。公告显示，公司于2026年4月3日召开第八届董事会第十七次会议，于2026年4月20日召开2026年第一次临时股东会，审议通过《关于变更回购股份用途并注销的议案》《关于减少注册资本及修订<公司章程>部分条款的议案》，同意注销公司回购专用证券账户中的10,887,600股股票，注册资本由491,061,461元减少至480,173,861元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000037317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","300381","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625936663","title":"溢多利(300381)3月31日股东户数2.02万户，较上期减少1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625936663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625936663?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:12","pubTimestamp":1775553141,"startTime":"0","endTime":"0","summary":"证券之星消息，近日溢多利披露，截至2026年3月31日公司股东户数为2.02万户，较2月27日减少205.0户，减幅为1.0%。在化学制药行业个股中，溢多利股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.47万户。从股价来看，2026年2月27日至2026年3月31日，溢多利区间跌幅为6.83%，在此期间股东户数减少205.0户，减幅为1.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700023996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300381","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624836543","title":"股市必读：溢多利（300381）4月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2624836543","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624836543?lang=zh_cn&edition=full","pubTime":"2026-04-02 00:54","pubTimestamp":1775062452,"startTime":"0","endTime":"0","summary":"截至2026年4月1日收盘，溢多利报收于6.67元，上涨1.83%，换手率1.95%，成交量9.53万手，成交额6343.04万元。董秘最新回复投资者： 请问公司去年预亏，今年一季度公司主营及毛利率环比有哪些积极变化？塑料降解酶中试进展何如？董秘： 您好，具体情况详见公司届时在巨潮资讯网披露的《2025年年度报告》及《2026年第一季度报告》，感谢您的关注！交易信息汇总资金流向4月1日主力资金净流出78.67万元；游资资金净流出23.79万元；散户资金净流入102.45万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200000651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","300381","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617165368","title":"溢多利公布国际专利申请：“碱性蛋白酶突变体及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2617165368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617165368?lang=zh_cn&edition=full","pubTime":"2026-03-07 05:44","pubTimestamp":1772833468,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示溢多利（300381）公布了一项国际专利申请，专利名为“碱性蛋白酶突变体及其应用”，专利申请号为PCT/CN2024/114740，国际公布日为2026年3月5日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来溢多利已公布的国际专利申请1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了4747.14万元，同比减2.48%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030700002605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0077","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617636517","title":"溢多利（300381）披露向2025年限制性股票激励计划激励对象授予预留限制性股票的公告，3月6日股价上涨3.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617636517","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617636517?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:36","pubTimestamp":1772807781,"startTime":"0","endTime":"0","summary":"近日，广东溢多利生物科技股份有限公司发布《关于向2025年限制性股票激励计划激励对象授予预留限制性股票的公告》。公告显示，公司于2026年3月6日召开董事会，确定向40名激励对象授予104万股第二类限制性股票，授予价格为3.63元/股，股票来源为二级市场回购及定向发行。本次授予的限制性股票归属期分别为自授予日起12个月、24个月、36个月后，归属比例为50%、50%。本次激励计划已履行相关审批程序，授予条件已满足。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600040450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0070","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616238019","title":"溢多利（300381）披露产品获得欧盟批准注册公告，3月2日股价下跌4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616238019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616238019?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:49","pubTimestamp":1772444945,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，溢多利报收于6.74元，较前一交易日下跌4.13%，最新总市值为33.1亿元。近日，广东溢多利生物科技股份有限公司发布公告称，其全资子公司德国Victory Enzymes GmbH获得欧盟委员会批准，其6-植酸酶产品可在欧盟市场作为猪、家禽及部分鸟类饲料添加剂使用，批准文号为 2026/404，有效期至2036年3月17日。该产品获批有助于丰富公司在欧盟市场的产品矩阵，完善全球化布局，提升饲用酶制剂领域的市场竞争力和品牌影响力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200026786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","FSXEmain","BK0077","BK0070","FESXmain","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616384692","title":"溢多利：截至2026年2月27日，公司股东人数为20415户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616384692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616384692?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:45","pubTimestamp":1772441118,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2月底的股东人数是多少？谢谢溢多利回复：您好，截至2026年2月27日，公司股东人数为20415户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200023194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300381","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616826195","title":"溢多利最新公告：公司产品获得欧盟批准注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826195","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616826195?lang=zh_cn&edition=full","pubTime":"2026-03-01 16:30","pubTimestamp":1772353841,"startTime":"0","endTime":"0","summary":"溢多利(300381.SZ)公告称，公司全资子公司德国Victory Enzymes GmbH 于近日获得欧盟委员会签发的批准文件，批准其植酸酶产品作为猪、家禽及部分鸟类饲料添加剂在欧盟市场使用。此次获批不仅丰富了公司在欧盟市场的产品矩阵，完善了公司全球化市场布局版图，还提升了公司在饲用酶制剂领域的市场竞争力和品牌影响力。但需注意，公司相关产品未来销售情况受多种因素影响，对公司业绩的影响具有不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100004437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","FSXEmain","BK0077","BK0070","FESXmain","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610198936","title":"溢多利：公司立足生物产业，致力于生物技术在营养与健康、食品饮料、护理清洁、纺织皮革、纸浆造纸、生物能源、生态农业、再生资源等领域的绿色、安全、高效应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2610198936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610198936?lang=zh_cn&edition=full","pubTime":"2026-02-10 15:04","pubTimestamp":1770707060,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利02月09日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000019012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0077","BK0070","000807.SH","159945","159843","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608947298","title":"股市必读：溢多利(300381)股东户数2.01万户，较上期增加1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608947298","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608947298?lang=zh_cn&edition=full","pubTime":"2026-02-03 03:05","pubTimestamp":1770059114,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，溢多利报收于6.7元，下跌1.9%，换手率1.44%，成交量7.07万手，成交额4799.38万元。当日关注点来自交易信息汇总：2月2日主力资金净流出7.12万元，游资资金净流入34.04万元。股本股东变化股东户数变动近日溢多利披露，截至2026年1月30日公司股东户数为2.01万户，较12月31日增加220.0户，增幅为1.11%。户均持股数量由上期的2.48万股减少至2.45万股，户均持股市值为16.73万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300001812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300381","BK0070","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606377713","title":"溢多利最新公告：2025年预亏1300万元—2600万元同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2606377713","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606377713?lang=zh_cn&edition=full","pubTime":"2026-01-28 19:40","pubTimestamp":1769600410,"startTime":"0","endTime":"0","summary":"溢多利(300381.SZ)发布业绩预告，预计2025年净利润亏损1300万元—2600万元，上年同期净利润3109.19万元，同比由盈转亏。报告期内，为维护老客户及推广新产品，销售费用有所增加；理财收益和利息收入减少；子公司计提资产减值损失及母公司产生固定资产报废损失。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800037492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300381","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778935520673,"stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.169},{"period":"3month","weight":0.1034},{"period":"6month","weight":-0.0106},{"period":"1year","weight":-0.0346},{"period":"ytd","weight":0.1457}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东溢多利生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20024人(较上一季度减少0.92%)","perCapita":"23893股","listingDate":"2014-01-28","address":"广东省珠海市香洲区南屏高科技工业区屏北一路8号","registeredCapital":"48017万元","survey":" 广东溢多利生物科技股份有限公司的主营业务是生物酶制剂、生物合成品及植物提取物的研发、生产、销售和服务，并向客户提供整体生物技术解决方案。公司的主要产品是生物酶制剂、生物合成品、植物提取物。公司荣获了国家工信部认定的“饲料用酶制剂产品国家制造业单项冠军企业”荣誉称号。","listedPrice":27.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"溢多利(300381)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供溢多利(300381)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"溢多利,300381,溢多利股票,溢多利股票老虎,溢多利股票老虎国际,溢多利行情,溢多利股票行情,溢多利股价,溢多利股市,溢多利股票价格,溢多利股票交易,溢多利股票购买,溢多利股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"溢多利(300381)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供溢多利(300381)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}